NexImmune's Seed Round

NexImmune raised a round of funding on February 03, 2012.

NexImmune is an early stage biopharmaceutical company developing immuno-therapeutics based on the Artificial IMmune (AIM) technology. The AIM technology provides an important advance in the developmen…

Articles about NexImmune's Seed Round: